PACS Group, Inc. PACS
General analysis — not personal advice.
Raised full-year EBITDA guidance, strong operating cash flow, and the buyback improve the risk/reward and provide downside support, though part of Q1 strength reflects more volatile incentive payments.
This picture changes. Follow PACS Group, Inc. free — email when the signal or risk changes + a Sunday weekly brief.
Follow PACS Group, Inc. freeEmail when the signal or risk changes · Sunday weekly brief
No card · No time limit on free tier · Upgrade when you need more
Price & valuation
Market sentiment
Why BUY?
- Consider adding in tranches (e.g., 1/3 now, 2/3 after Q2 confirmation), monitoring margins excluding WQIP and occupancy trends.
Recent News
- On Sep 29, 2026, PACS entered an agreement to acquire operations of 34 skilled nursing facilities from Eduro Healthcare across multiple states (including Texas), adding 3,633 beds; closing is expected in multiple tranches, primarily in Q3 2026, subject to regulatory approvals. Previously (May 11, 2026), the company reported strong Q1 2026 results, raised FY2026 adjusted EBITDA guidance ($605–$625M), and authorized a $250M share repurchase program.
Catalysts
Closing of Eduro portfolio (34 facilities)
Dilution Risk
Assessment: Low
What Firelda Watch includes for PACS Group, Inc.
Add the company to your watchlist and get all of this automatically.
- Free: 3 companies on your watchlist
- Change history and monitoring for every company you follow
- Sunday weekly brief — AI roundup of the week's news
- Watch/Ultra: same-day email when something material happens
Want to see what a finished analysis looks like?
View a sample analysis
Own PACS Group, Inc.? Create a free account and follow up to 3 companies — change history, weekly brief, and email when the picture changes. Upgrade to Watch for more slots and same-day alerts.
Follow 3 companies freeEmail when the signal or risk changes · Sunday weekly brief
No card · No time limit on free tier · Upgrade when you need more